Bioelectronics Corp Current Ratio vs. Price To Sales
| BIEL Stock | USD 0.0003 0.0001 50.00% |
For Bioelectronics Corp profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bioelectronics Corp to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bioelectronics Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bioelectronics Corp's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bioelectronics Corp over time as well as its relative position and ranking within its peers.
Bioelectronics |
Bioelectronics Corp Price To Sales vs. Current Ratio Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Bioelectronics Corp's current stock value. Our valuation model uses many indicators to compare Bioelectronics Corp value to that of its competitors to determine the firm's financial worth. Bioelectronics Corp is number one stock in current ratio category among its peers. It also is number one stock in price to sales category among its peers fabricating about 3,073 of Price To Sales per Current Ratio. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bioelectronics Corp's earnings, one of the primary drivers of an investment's value.Bioelectronics Price To Sales vs. Current Ratio
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Bioelectronics Corp |
| = | 0.01 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Bioelectronics Corp |
| = | 30.73 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Bioelectronics Price To Sales Comparison
Bioelectronics Corp is currently under evaluation in price to sales category among its peers.
Bioelectronics Corp Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Bioelectronics Corp, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bioelectronics Corp will eventually generate negative long term returns. The profitability progress is the general direction of Bioelectronics Corp's change in net profit over the period of time. It can combine multiple indicators of Bioelectronics Corp, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. The company was incorporated in 2000 and is headquartered in Frederick, Maryland. BIOELECTRONICS CORP operates under Medical Devices classification in the United States and is traded on OTC Exchange.
Bioelectronics Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Bioelectronics Corp. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bioelectronics Corp position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bioelectronics Corp's important profitability drivers and their relationship over time.
Use Bioelectronics Corp in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioelectronics Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioelectronics Corp will appreciate offsetting losses from the drop in the long position's value.Bioelectronics Corp Pair Trading
Bioelectronics Corp Pair Trading Analysis
The ability to find closely correlated positions to Bioelectronics Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bioelectronics Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bioelectronics Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bioelectronics Corp to buy it.
The correlation of Bioelectronics Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bioelectronics Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bioelectronics Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bioelectronics Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Bioelectronics Corp position
In addition to having Bioelectronics Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Target Outcome ETFs Thematic Idea Now
Target Outcome ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Target Outcome ETFs theme has 92 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Target Outcome ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Bioelectronics Pink Sheet
To fully project Bioelectronics Corp's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Bioelectronics Corp at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Bioelectronics Corp's income statement, its balance sheet, and the statement of cash flows.